About this event

  • Date and time Fri 8 Dec 2023 from 9:00am to 5:00pm
  • Location Royal Society of Medicine
  • Organised by Urology

 

Join this event which brings together key opinion leaders in the major urological cancers to explore the current standards of care and to ask what the future might look like. Experts in kidney, prostate, bladder and testicular cancer will provide concise and incisive updates on their subject areas before participating in discussion of future developments. 

The aim of this meeting is to provide an overview of the contemporary management of patients with urological cancer, and explore future directions and is aimed at urologists in training and urology nurses as well as consultants from across the multidisciplinary team. 

Benefits of attending:

  • Increase your knowledge on the current management of urological cancers 
  • Gain an understanding of the relative benefits and harms of treatments for urological cancers 
  • Improve attitudes towards a multidisciplinary approach when managing patients with urological cancers 
  • Become mentally prepared for future changes in the management of urological cancers  

---

Winter short paper prize

Deadline: Thursday 12 October 2023

Open to: UK-based aspiring urologists

Apply here

Follow us on
Facebook 
Instagram
LinkedIn
Twitter 
YouTube 

We would like to thank our sponsors Accord, Bayer, Cambridge Clinical Laboratories, Ferring Pharmaceuticals, Henleys Medical Supplies, Janssen, medac Pharma and Photocure for their support of this event. Please note that the main scientific programme and content has not been influenced in any way by the sponsors.

Show Virtual / In Person rates

Agenda

View the programme (in-person)

Registration, tea and coffee
Welcome and introduction

Professor James Green, President, Urology Section, Royal Society of Medicine 

Prostate cancer

Radical treatment for localised prostate cancer: More harm than good?

Chairs: Dr Karen Tipples, Consultant Clinical Oncologist, Barts Health NHS Trust and Ms Louisa Fleure, Consultant Nurse, Guy’s and St Thomas’ NHS Foundation Trust

Hard to reach populations: Who should we be testing?

Professor Nicholas James, Professor of Prostate and Bladder Cancer Research, The Royal Marsden NHS Foundation Trust

Improving prostatectomy to improve patient outcomes
Professor Imran Ahmad, Professor of Urological Oncology, University of Glasgow
Modern radiotherapy techniques to minimise side effects

Dr Alexander Martin, Consultant Clinical Oncologist, Cambridge University Hospitals NHS Foundation Trust

The critical importance of understanding prognosis to individualise treatment decisions in prostate cancer

Professor Vincent Gnanapragasam, Professor of Urology and Honorary Consultant Urologist, University of Cambridge

Panel discussion

Testicular cancer

Multidisciplinary approach and need for surgical treatment. Future reorganisation of testicular cancer treatment? Single centre?

Chair: Professor Prabhakar Rajan, Consultant Urologist, Queen Mary University of London

Multidisciplinary approach and need for surgical treatment in testicular cancer

Dr Jonathan Shamash, Consultant Medical Oncologist, Barts Health NHS Trust

Panel discussion
Tea and coffee break

Bladder cancer

Are the days of trans urethral resection of bladder tumour (TURBT) for muscle invasive bladder cancer (MIBC) numbered, and even for cystectomy? 

Chairs: Dr Bernadett Szabados, Urologic Oncologist, University College London Hospitals NHS Foundation Trust, Barts Cancer Institute and Ms Jo Cresswell, President, The British Association of Urological Surgeons (BAUS)

Early detection and patient selection using biomarkers

Professor Rik Bryan, Director, Bladder Cancer Research Centre, University of Birmingham

Improving cystectomy: Robotics

Professor Nikhil Vasdev, Professor and Chair of Robotic Surgery, School of Life and Medical Sciences, University of Hertfordshire, Consultant Urological and Robotic Surgeon, Hertfordshire and Bedfordshire Urological Cancer Centre, Lister Hospital

Avoiding TURBT, bladder sparing options in MIBC

Professor Nicholas James, Professor of Prostate and Bladder Cancer Research, The Royal Marsden NHS Foundation Trust

Panel discussion

Histopathology

How pathologists can help you to care for your patients

Chair to be confirmed

How your pathologist can help you

Professor Dan Berney, Honorary Professor of Genito-urinary Pathology, Consultant Pathologist, Barts Health NHS Trust 

Lunch break

Kidney cancer

Screening and the role of the MDT in managing kidney cancer 

Chairs: Mr Prasad Patki, Consultant Urologist, Barts Health NHS Trust and Mr Ravi Barod, Consultant Urological Surgeon, Royal Free London NHS Foundation Trust

Screening for kidney cancer and the MDT approach

Professor Grant Stewart, Professor of Surgical Oncology, Cambridge University Hospitals NHS Foundation Trust 

Non-surgical options in kidney cancer

Professor Tom Powles, Professor of Oncology, Queen Mary University of London

Minimally invasive treatments for renal cancer

Professor Maxine Tran, Professor of Urology, Royal Free London NHS Foundation Trust 

Panel discussion
Computer aided detection in prostate cancer screening: Elementary or rudimentary?

Mr Nikhil Mayor, Academic Clinical Fellow in Urology and Specialty Trainee Year 3, Imperial College London

Winter short papers prize presentation

The role of biopsy in small renal masses under 4cm: A European modified Delphi consensus statement

Mr Darryl Bernstein, Urology Academic Clinical Fellow, Specialty Trainee Year 4 Registrar and Honorary Research Associate, Royal Free Hospital NHS Foundation Trust

Winter short papers prize presentation

Men referred with suspicious digital rectal exam (DRE) findings in combination with a raised Prostate-Specific antigen (PSA) have a higher odd of clinically significant prostate cancer than raised PSA or DRE alone

Mr Chris Richards, Urology Core Trainee Year 2, Stockport NHS Foundation Trust

Winter short papers prize presentation

Minimally invasive marvel: Descriptive report of supine mini percutaneous nephrolithotomy (PCNL) outcomes across a variety of stone complexity and sizes: Single-centre study

Dr Daniela Ioana Mateescu, Urology Core Trainee Year 2 Trust Grade, Darent Valley Hospital, Dartford and Gravesham NHS Trust

Winter short papers prize presentation

Tea and coffee break
Is navigation treatment of postmenopausal recurrent urinary tract infections (UTIs) difficult?

Mr Yehia Abdelmotagly, Urology Specialty Trainee Year 3, James Cook University Hospital, South Tees Hospitals NHS Foundation Trust

Winter short papers prize presentation

Cardiovascular risk associated with Luteinizing hormone-releasing hormone (LHRH) analogue treatment and assessing those at risk: A retrospective cohort study

Dr John Gibson, Core Trainee Year 1, East Lancashire Hospitals NHS Trust

Winter short papers prize presentation

Evaluating representation: A demographics analysis of the study participants in the NEphron Sparing Treatment (NEST) clinical trial

Mr Joseph Santiapillai, Urology Trainee and PhD Student, University College London

Winter short papers prize presentation

The importance of multiparametric Magnetic Resonance Imaging (MRI) versus other parameters in predicting the detection of localized radiorecurrent prostate cancer: An analysis from the forecast trial

Mr Alexander Light, Academic Clinical Fellow and Specialty Trainee Year 3, Imperial College Healthcare NHS Trust

Winter short papers prize presentation

Training

Future of surgery training: Open and robotic

Chairs: Mr Ross Warner, Post-CCT Urology Robotic Fellow, East and North Hertfordhsire NHS Trust and Ms Sarika Nalagatla, Urology Specialist Trainee Year 7, Queen Elizabeth University Hospital

Future of robotic surgical training

Dr Justin Collins, Consultant Urologist, University College London Hospitals NHS Foundation Trust

Future of open surgical training

Professor Phil Cornford, Consultant Urologist, Liverpool University Hospitals NHS Foundation Trust

Panel discussion
Closing remarks

Professor James Green, President, Urology Section, Royal Society of Medicine

Winter short papers prize winner announcements

Close of meeting
View the programme (virtual)

Welcome and introduction

Professor James Green, President, Urology Section, Royal Society of Medicine 

Prostate cancer

Radical treatment for localised prostate cancer: More harm than good?

Chairs: Dr Karen Tipples, Consultant Clinical Oncologist, Barts Health NHS Trust and Ms Louisa Fleure, Consultant Nurse, Guy’s and St Thomas’ NHS Foundation Trust

Hard to reach populations: Who should we be testing?

Professor Nicholas James, Professor of Prostate and Bladder Cancer Research, The Royal Marsden NHS Foundation Trust

Improving prostatectomy to improve patient outcomes

Professor Imran Ahmad, Professor of Urological Oncology, University of Glasgow

Modern radiotherapy techniques to minimise side effects

Dr Alexander Martin, Consultant Clinical Oncologist, Cambridge University Hospitals NHS Foundation Trust

The critical importance of understanding prognosis to individualise treatment decisions in prostate cancer

Professor Vincent Gnanapragasam, Professor of Urology and Honorary Consultant Urologist, University of Cambridge

Panel discussion

Testicular cancer

Multidisciplinary approach and need for surgical treatment. Future reorganisation of testicular cancer treatment? Single centre?

Chair: Professor Prabhakar Rajan, Consultant Urologist, Queen Mary University of London

Multidisciplinary approach and need for surgical treatment in testicular cancer

Dr Jonathan Shamash, Consultant Medical Oncologist, Barts Health NHS Trust

Panel discussion
Comfort break

Bladder cancer

Are the days of trans urethral resection of bladder tumour (TURBT) for muscle invasive bladder cancer (MIBC) numbered, and even for cystectomy? 

Chairs: Dr Bernadett Szabados, Urologic Oncologist, University College London Hospitals NHS Foundation Trust, Barts Cancer Institute and Ms Jo Cresswell, President, The British Association of Urological Surgeons (BAUS)

Early detection and patient selection using biomarkers

Professor Rik Bryan, Director, Bladder Cancer Research Centre, University of Birmingham

Improving cystectomy: Robotics

Professor Nikhil Vasdev, Professor and Chair of Robotic Surgery, School of Life and Medical Sciences, University of Hertfordshire, Consultant Urological and Robotic Surgeon, Hertfordshire and Bedfordshire Urological Cancer Centre, Lister Hospital

Avoiding TURBT, bladder sparing options in MIBC

Professor Nicholas James, Professor of Prostate and Bladder Cancer Research, The Royal Marsden NHS Foundation Trust

Panel discussion

Histopathology

How pathologists can help you to care for your patients.

Chair to be confirmed

How your pathologist can help you

Professor Dan Berney, Honorary Professor of Genito-urinary Pathology, Consultant Pathologist, Barts Health NHS Trust

Lunch break

Kidney cancer

Screening and the role of the MDT in managing kidney cancer 

Chairs: Mr Prasad Patki, Consultant Urologist, Barts Health NHS Trust and Mr Ravi Barod, Consultant Urological Surgeon, Royal Free London NHS Foundation Trust

Screening for kidney cancer and the MDT approach

Professor Grant Stewart, Professor of Surgical Oncology, Cambridge University Hospitals NHS Foundation Trust 

Non-surgical options in kidney cancer

Professor Tom Powles, Professor of Oncology, Queen Mary University of London

Minimally invasive treatments for renal cancer

Professor Maxine Tran, Professor of Urology, Royal Free London NHS Foundation Trust 

Panel discussion
Computer aided detection in prostate cancer screening: Elementary or rudimentary?

Mr Nikhil Mayor, Academic Clinical Fellow in Urology and Specialty Trainee Year 3, Imperial College London

Winter short papers prize presentation

The role of biopsy in small renal masses under 4cm: A European modified Delphi consensus statement

Mr Darryl Bernstein, Urology Academic Clinical Fellow, Specialty Trainee Year 4 Registrar and Honorary Research Associate, Royal Free Hospital NHS Foundation Trust

Winter short papers prize presentation

Men referred with suspicious digital rectal exam (DRE) findings in combination with a raised Prostate-Specific antigen (PSA) have a higher odd of clinically significant prostate cancer than raised PSA or DRE alone

Mr Chris Richards, Urology Core Trainee Year 2, Stockport NHS Foundation Trust

Winter short papers prize presentation

Minimally invasive marvel: Descriptive report of supine mini percutaneous nephrolithotomy (PCNL) outcomes across a variety of stone complexity and sizes: Single-centre study

Dr Daniela Ioana Mateescu, Urology Core Trainee Year 2 Trust Grade, Darent Valley Hospital, Dartford and Gravesham NHS Trust

Winter short papers prize presentation

Comfort break
Is navigation treatment of postmenopausal recurrent urinary tract infections (UTIs) difficult?

Mr Yehia Abdelmotagly, Urology Specialty Trainee Year 3, James Cook University Hospital, South Tees Hospitals NHS Foundation Trust

Winter short papers prize presentation

Cardiovascular risk associated with Luteinizing hormone-releasing hormone (LHRH) analogue treatment and assessing those at risk: A retrospective cohort study

Dr John Gibson, Core Trainee Year 1, East Lancashire Hospitals NHS Trust

Winter short papers prize presentation

Evaluating representation: A demographics analysis of the study participants in the NEphron Sparing Treatment (NEST) clinical trial

Mr Joseph Santiapillai, Urology Trainee and PhD Student, University College London

Winter short papers prize presentation

The importance of multiparametric Magnetic Resonance Imaging (MRI) versus other parameters in predicting the detection of localized radiorecurrent prostate cancer: An analysis from the forecast trial

Mr Alexander Light, Academic Clinical Fellow and Specialty Trainee Year 3, Imperial College Healthcare NHS Trust

Winter short papers prize presentation

Training

Future of surgery training: Open and robotic

Chairs: Mr Ross Warner, Post-CCT Urology Robotic Fellow, East and North Hertfordhsire NHS Trust and Ms Sarika Nalagatla, Urology Specialist Trainee Year 7, Queen Elizabeth University Hospital

Future of robotic surgical training

Dr Justin Collins, Consultant Urologist, University College London Hospitals NHS Foundation Trust

Future of open surgical training

Professor Phil Cornford, Consultant Urologist, Liverpool University Hospitals NHS Foundation Trust

Panel discussion
Closing remarks

Professor James Green, President, Urology Section, Royal Society of Medicine

Winter short papers prize winner announcements

Close of meeting

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

 

Registration for this event will close at 1:00am on Thursday 7 December 2023. Late registrations will not be accepted.

The agenda is subject to change at any time

If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM’s discretion.

All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.

This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.

 

Domus - reception

While you’re attending this event

Why not stay in the comfort of our hotel, Domus Medica, book dinner in the restaurant, or even hire one of our private dining rooms to socialise with your peers?

RSM members enjoy access to our enviable club facilities. For more information, please contact our team at domus@rsm.ac.uk or restaurant@rsm.ac.uk.

Find out more